Sign Up to like & get
recommendations!
0
Published in 2020 at "Current Neurology and Neuroscience Reports"
DOI: 10.1007/s11910-020-01042-6
Abstract: Purpose of Review Glioblastoma (GBM) is the most common malignant primary brain tumor, and the available treatment options are limited. This article reviews the recent preclinical and clinical investigations that seek to expand the repertoire…
read more here.
Keywords:
therapies glioblastoma;
novel therapies;
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Nutrition"
DOI: 10.3389/fnut.2023.1110291
Abstract: Glioblastoma Multiforme is an aggressive brain cancer affecting children and adults frequently resulting in a short life expectancy. Current cancer therapies include surgery and radiation followed by chemotherapy, which due to their ineffectiveness, requires repeated…
read more here.
Keywords:
ketogenic diet;
therapies glioblastoma;
ketogenic therapies;
glioblastoma understanding ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2018.00464
Abstract: Targeting the Immune Checkpoint molecules (ICs; CTLA-4, PD-1, PD-L1/2, and others) which provide inhibitory signals to T cells, dramatically improves survival in hard-to-treat tumors. The establishment of an immunosuppressive environment prevents endogenous immune response in…
read more here.
Keywords:
checkpoints innovative;
therapies glioblastoma;
innovative therapies;
immune checkpoints ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancers"
DOI: 10.3390/cancers12010242
Abstract: Traditional anti-cancer treatments are inefficient against glioblastoma, which remains one of the deadliest and most aggressive cancers. Nano-drugs could help to improve this situation by enabling: (i) an increase of anti-glioblastoma multiforme (GBM) activity of…
read more here.
Keywords:
nano therapies;
therapies glioblastoma;
glioblastoma treatment;
tumor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Cancer Research and Therapeutics"
DOI: 10.4103/jcrt.jcrt_1324_21
Abstract: Glioblastoma multiforme (GBM) affects individuals above 65 years of age and has low median survival rate. Due to limited treatment options, lack of effective diagnosis, and palliative care, there is an urgent need to develop…
read more here.
Keywords:
overview targets;
glioblastoma multiforme;
therapies glioblastoma;
targets therapies ... See more keywords